Kane Biotech Inc V.KNE

Alternate Symbol(s): KNBIF

Healthcare Biotechnology

Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired from research institutions. DispersinB, coactiv+, coactiv+, DermaKB, DermaKB Biofilm, and revive are trademarks of the Company. Its patented coactiv+ technology is specifically formulated to destabilize biofilm and create an environment for fast wound healing. In Wound Care & Surgical applications, in addition to revyve Antimicrobial Wound Gel, it is developing follow-on products with three applications: coactiv+ Antimicrobial Surgical Hydrogel, coactiv+ Antimicrobial Wound Gel Spray, and coactiv+ Antimicrobial Wound Rinse. The Company's other biofilm disruption technology is DispersinB.

TSXV:KNE - Post by User

Kane Biotech Inc > News required to move price upwards

<< Previous

Bullboard Posts

Next >>

Comment by francoisl13on Oct 10, 2023 4:21pm

71 Views

Post# 35677664

RE:RE:RE:RE:RE:News required to move price upwards

Thanks RoyMax123 for sharing the info...I must have been blind not to see the video and the (very nice) photo of the Coactiv+ product. I was waiting for a press release regarding the production of the Coactiv+ product but we got the info from Facebook and LinkedIN well, it is where news and info are being shared these days so,I better start looking more regularly at those site.
P.S. I really like this company and the product lines they have (will have), looks very promising but it is such a small company that it takes a lot of time to be noticed by the market.
GLTA

<< Previous

Bullboard Posts

Next >>

Understanding tax loss season and the “Santa Claus rally”